导师类型：硕士生导师
单 位：01西苑医院
出生年月：1972年12月
专业职务：研究员
学 位：医学博士
毕业学校：中国中医科学院
第一学科：中西医结合
第二学科：中西医结合基础
研究方向：中药药理学；心脑血管病及阿尔茨海默病的中西医结合临床与基础研究
联系电话：62835568
邮 箱：yuanrong427@163.com
邮 编：100091
联系地址：北京海淀西苑操场1号实验楼305室
个人简介：丛伟红，山东青岛人。医学博士，首届中医药传承博士后，美国Wake Forest大学博士后，研究员，现任中国中医科学院西苑医院心血管病实验室、国家（中医）心血管病临床医学研究中心实验室主任，澳门科技大学、天津中医药大学、广西中医药大学等客座教授。从事中西医结合基础、临床研究及新药研发20余年，主持或主研参与国家及省部级课题20余项，包括亚太经合组织（APEC）迄今支持的唯一一个中医药项目。主要研究方向为中西医结合防治心脑血管病和阿尔茨海默病，以第一或通讯作者发表论文60余篇（[i]The New England Journal of Medicine[/i]、[i]Gastroenterology、Pharmacological Research[/i]等），主编、参编著作7部（1部在美国出版），获中华中医药学会科学技术一等奖、二等奖及北京市、中国中医科学院科技进步二等奖多项，申请、获得专利各1项。现为国家自然科学基金、首都医疗卫生发展专项、中国博士后基金等项目和北京市自然科学研究系列职称评审专家，[i]Chin J Integra Med[/i]、[i]Mol Pharmacol[/i]、[i]Front Pharmacol、[/i]《中国中药杂志》等杂志编委，“一带一路”及葡语系国家天然药物创新联盟（澳门）副会长、中国民族医药学会心身医学分会副会长、中国老年学和老年医学学会中西医结合学会常委兼副总干事以及其他多个学术团体的常委或理事。2017年获全国大型公益评选“荣耀医者”青年创新奖，是10名获奖者中唯一一名来自中医药单位的获奖者；2019年入选全国中医药传承与创新“百千万”人才（西医学习中医优秀人才培养对象）。
论文：
Efficacy and safety of liraglutide in type 2 diabetes mellitus patients complicated with coronary artery disease: A systematic review and meta-analysis of randomized controlled trials Pharmacological Research 2021/7/9
中医整体观指导下的COVID-19治疗——同时着眼于病毒和宿主的疗法 中国中药杂志 2020/3/1
Re: Effect of aspirin on disability-free survival in the healthy elderly The New England Journal of Medicine 2019/5/2
Reply: incidence and etiology of drug-induced liver injury in mainland China Gastroenterology 2019/8/1
Tetramethylpyrazine and paeoniflorin inhibit oxidized LDL-induced angiogenesis in human umbilical vein endothelial cells via VEGF and Notch pathways ECAM 2018/6/1
Holistic regulation of angiogenesis with Chinese herbal medicines as a new option for coronary artery disease ECAM 2018/8/1
Chinese herbal medicines facilitate the control of chemotherapy-induced side effects in colorectal cancer: progress and perspective Front Pharmacol 2018/12/7
Puerarin reduces blood pressure in spontaneously hypertensive rats by targeting eNOS American J Chinese Med 2019/1/1
Chinese medicines improve perimenopausal symptoms induced by surgery, chemoradiotherapy or endocrine treatment for breast cancer Front Pharmacol 2019/3/1
Neovascularization: The Main Mechanism of MSCs in Ischemic Heart Disease Therapy Front Cardiovasc Med 2021/1/1
A new therapeutic candidate for cardiovascular diseases: berberine Front Pharmacol 2021/5/1
美国FDA认同传统中医药学是整体医学 中国中西医结合杂志 2007/6/1
Effect of combination of extracts of ginseng and ginkgo biloba on acetylcholine in amyloid beta-peptide-treated rats determined by an improved HPL Acta Pharmacol Sin 2004/9/1
Herbal extracts combination (WNK) prevents decline in spatial learning and memory in APP/PS1 mice through improvement of hippocampal Aβ plaque formation, histopathology, and ultrastructure ECAM 2012/5/1
Pro-angiogenic activity of notoginsenoside R1 in HUVECs in vitro and in a chemical-induced blood vessel loss model of zebrafish in vivo Chin J of Integr Med 2014/12/1
Rapid profiling and identification of puerarin metabolites in rat urine and plasma after oral administration by UHPLC-LTQ-Orbitrap mass spectrometer J Chromatogr B 2017/10/1
Vascular endothelial growth factor gene transfer therapy for coronary artery disease: a systematic review and meta-analysis Cardiovasc Ther 2018/7/1
A novel Ca2+ current blocker promotes angiogenesis and cardiac healing after experimental myocardial infarction in mice, Pharmacological research Pharmacological research 2018/7/1
专著：
老年医学 科学技术文献出版社
杏苑泽霖录 人民卫生出版社
Modern Advances in Pharmaceutical Research Book Publisher International
全国大型公益评选“荣耀医者”青年创新奖 其他
基于脉的气虚血瘀证的生物学机制研究 中华中医药学会科学技术奖
治疗缺血性脑损伤及神经退行性病变中药药效学评价的方法学研究 省级科研奖励中国专利奖
获奖：
Efficacy and safety of liraglutide in type 2 diabetes mellitus patients complicated with coronary artery disease: A systematic review and meta-analysis of randomized controlled trials Pharmacological Research
中医整体观指导下的COVID-19治疗——同时着眼于病毒和宿主的疗法 中国中药杂志
Re: Effect of aspirin on disability-free survival in the healthy elderly The New England Journal of Medicine
Reply: incidence and etiology of drug-induced liver injury in mainland China Gastroenterology
Tetramethylpyrazine and paeoniflorin inhibit oxidized LDL-induced angiogenesis in human umbilical vein endothelial cells via VEGF and Notch pathways ECAM
Holistic regulation of angiogenesis with Chinese herbal medicines as a new option for coronary artery disease ECAM
Chinese herbal medicines facilitate the control of chemotherapy-induced side effects in colorectal cancer: progress and perspective Front Pharmacol
Puerarin reduces blood pressure in spontaneously hypertensive rats by targeting eNOS American J Chinese Med
Chinese medicines improve perimenopausal symptoms induced by surgery, chemoradiotherapy or endocrine treatment for breast cancer Front Pharmacol
Neovascularization: The Main Mechanism of MSCs in Ischemic Heart Disease Therapy Front Cardiovasc Med
A new therapeutic candidate for cardiovascular diseases: berberine Front Pharmacol
美国FDA认同传统中医药学是整体医学 中国中西医结合杂志
Effect of combination of extracts of ginseng and ginkgo biloba on acetylcholine in amyloid beta-peptide-treated rats determined by an improved HPL Acta Pharmacol Sin
Herbal extracts combination (WNK) prevents decline in spatial learning and memory in APP/PS1 mice through improvement of hippocampal Aβ plaque formation, histopathology, and ultrastructure ECAM
Pro-angiogenic activity of notoginsenoside R1 in HUVECs in vitro and in a chemical-induced blood vessel loss model of zebrafish in vivo Chin J of Integr Med
Rapid profiling and identification of puerarin metabolites in rat urine and plasma after oral administration by UHPLC-LTQ-Orbitrap mass spectrometer J Chromatogr B
Vascular endothelial growth factor gene transfer therapy for coronary artery disease: a systematic review and meta-analysis Cardiovasc Ther
A novel Ca2+ current blocker promotes angiogenesis and cardiac healing after experimental myocardial infarction in mice, Pharmacological research Pharmacological research
